The study suggested that high oxytocin receptor levels are associated with increased EGF sensitivity and that oxytocin receptors promote EGF-stimulated RSK activation via the mTOR pathway, leading to downstream rpS6 activation and enhanced migration of breast cancer cells. Here, EGF is linked to breast carcinoma.